• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺激素对大鼠肝脏低密度脂蛋白受体和胆固醇7α羟化酶的转录调控。

Transcriptional regulation of rat hepatic low-density lipoprotein receptor and cholesterol 7 alpha hydroxylase by thyroid hormone.

作者信息

Ness G C, Lopez D

机构信息

Department of Biochemistry and Molecular Biology, College of Medicine, University of South Florida, Tampa 33612, USA.

出版信息

Arch Biochem Biophys. 1995 Nov 10;323(2):404-8. doi: 10.1006/abbi.1995.0061.

DOI:10.1006/abbi.1995.0061
PMID:7487105
Abstract

Utilizing hypophysectomized and thyroidectomized rats, it is demonstrated that the rapid increase in expression of hepatic low-density lipoprotein (LDL) receptor and cholesterol 7 alpha-hydroxylase in response to thyroid hormone is due to increases in the rates of transcription of these genes. An increase in transcription of the hepatic LDL receptor gene was seen within 30 min after administration of triiodothyronine. The increase in transcription fully accounted for the increase in hepatic LDL receptor protein. Stimulation of transcription of these two genes provides for enhanced removal of LDL from serum and elimination from the body.

摘要

利用垂体切除和甲状腺切除的大鼠,已证明肝脏低密度脂蛋白(LDL)受体和胆固醇7α-羟化酶对甲状腺激素反应的表达快速增加是由于这些基因转录速率的增加。给予三碘甲状腺原氨酸后30分钟内可见肝脏LDL受体基因转录增加。转录的增加完全解释了肝脏LDL受体蛋白的增加。这两个基因转录的刺激有助于增强从血清中清除LDL并从体内消除。

相似文献

1
Transcriptional regulation of rat hepatic low-density lipoprotein receptor and cholesterol 7 alpha hydroxylase by thyroid hormone.甲状腺激素对大鼠肝脏低密度脂蛋白受体和胆固醇7α羟化酶的转录调控。
Arch Biochem Biophys. 1995 Nov 10;323(2):404-8. doi: 10.1006/abbi.1995.0061.
2
Effects of L-triiodothyronine and the thyromimetic L-94901 on serum lipoprotein levels and hepatic low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and apo A-I gene expression.L-三碘甲状腺原氨酸及拟甲状腺素L-94901对血清脂蛋白水平以及肝脏低密度脂蛋白受体、3-羟基-3-甲基戊二酰辅酶A还原酶和载脂蛋白A-I基因表达的影响。
Biochem Pharmacol. 1998 Jul 1;56(1):121-9. doi: 10.1016/s0006-2952(98)00119-1.
3
Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase unmask transcriptional regulation of hepatic low-density lipoprotein receptor gene expression by dietary cholesterol.3-羟基-3-甲基戊二酰辅酶A还原酶抑制剂揭示了膳食胆固醇对肝脏低密度脂蛋白受体基因表达的转录调控。
Arch Biochem Biophys. 1997 Aug 1;344(1):215-9. doi: 10.1006/abbi.1997.0193.
4
Effect of thyroid hormone on hepatic cholesterol 7 alpha hydroxylase, LDL receptor, HMG-CoA reductase, farnesyl pyrophosphate synthetase and apolipoprotein A-I mRNA levels in hypophysectomized rats.
Biochem Biophys Res Commun. 1990 Nov 15;172(3):1150-6. doi: 10.1016/0006-291x(90)91568-d.
5
Thyroid hormone rapidly increases cholesterol 7 alpha-hydroxylase mRNA levels in hypophysectomized rats.
Biochim Biophys Acta. 1994 Oct 6;1214(3):229-33. doi: 10.1016/0005-2760(94)90068-x.
6
Inhibitors of cholesterol biosynthesis increase hepatic low-density lipoprotein receptor protein degradation.胆固醇生物合成抑制剂会增加肝脏低密度脂蛋白受体蛋白的降解。
Arch Biochem Biophys. 1996 Jan 15;325(2):242-8. doi: 10.1006/abbi.1996.0030.
7
Thyroid hormone rapidly induces hepatic LDL receptor mRNA levels in hypophysectomized rats.
Arch Biochem Biophys. 1994 Nov 15;315(1):199-202. doi: 10.1006/abbi.1994.1490.
8
Novel effects of histamine on lipoprotein metabolism: suppression of hepatic low density lipoprotein receptor expression and reduction of plasma high density lipoprotein cholesterol in the rat.组胺对脂蛋白代谢的新作用:抑制大鼠肝脏低密度脂蛋白受体表达并降低血浆高密度脂蛋白胆固醇水平
Endocrinology. 1997 May;138(5):1863-70. doi: 10.1210/endo.138.5.5115.
9
Loss of resistance to dietary cholesterol in the rat after hypophysectomy: importance of the presence of growth hormone for hepatic low density lipoprotein-receptor expression.垂体切除术后大鼠对膳食胆固醇的抗性丧失:生长激素的存在对肝脏低密度脂蛋白受体表达的重要性。
Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):8851-5. doi: 10.1073/pnas.90.19.8851.
10
Prolonged stimulation of the adrenals by corticotropin suppresses hepatic low-density lipoprotein and high-density lipoprotein receptors and increases plasma cholesterol.促肾上腺皮质激素对肾上腺的长期刺激会抑制肝脏低密度脂蛋白和高密度脂蛋白受体,并增加血浆胆固醇。
Endocrinology. 2002 May;143(5):1809-16. doi: 10.1210/endo.143.5.8816.

引用本文的文献

1
Lipid Hormones at the Intersection of Metabolic Imbalances and Endocrine Disorders.代谢失衡与内分泌紊乱交叉点上的脂质激素
Curr Issues Mol Biol. 2025 Jul 18;47(7):565. doi: 10.3390/cimb47070565.
2
Drug discovery targeting thyroid hormone receptor (THR) for the treatment of liver diseases and other medical indications.以甲状腺激素受体(THR)为靶点进行药物研发,用于治疗肝脏疾病及其他医学适应症。
Acta Pharm Sin B. 2025 Jan;15(1):35-51. doi: 10.1016/j.apsb.2024.07.025. Epub 2024 Aug 2.
3
Gallstone Disease and Its Correlation With Thyroid Disorders: A Narrative Review.
胆结石病及其与甲状腺疾病的相关性:一篇叙述性综述。
Cureus. 2023 Sep 12;15(9):e45116. doi: 10.7759/cureus.45116. eCollection 2023 Sep.
4
Thyroid hormone action and liver disease, a complex interplay.甲状腺激素作用与肝脏疾病:复杂的相互作用
Hepatology. 2025 Feb 1;81(2):651-669. doi: 10.1097/HEP.0000000000000551. Epub 2023 Aug 2.
5
Important Hormones Regulating Lipid Metabolism.重要的脂质代谢调节激素。
Molecules. 2022 Oct 19;27(20):7052. doi: 10.3390/molecules27207052.
6
Update on dyslipidemia in hypothyroidism: the mechanism of dyslipidemia in hypothyroidism.甲状腺功能减退症血脂异常的最新进展:甲状腺功能减退症血脂异常的机制
Endocr Connect. 2022 Feb 7;11(2):e210002. doi: 10.1530/EC-21-0002.
7
Novel insights into the pathological development of dyslipidemia in patients with hypothyroidism.探讨甲状腺功能减退症患者血脂异常病理发展的新见解。
Bosn J Basic Med Sci. 2022 Jun 1;22(3):326-339. doi: 10.17305/bjbms.2021.6606.
8
Classification of thyroid hormone receptor agonists and antagonists using statistical learning approaches.使用统计学习方法对甲状腺激素受体激动剂和拮抗剂进行分类。
Mol Divers. 2019 Feb;23(1):85-92. doi: 10.1007/s11030-018-9857-9. Epub 2018 Jul 16.
9
Direct effects of thyroid hormones on hepatic lipid metabolism.甲状腺激素对肝脏脂质代谢的直接影响。
Nat Rev Endocrinol. 2018 May;14(5):259-269. doi: 10.1038/nrendo.2018.10. Epub 2018 Feb 23.
10
3,5,3'-Triiodo-L-Thyronine- and 3,5-Diiodo-L-Thyronine- Affected Metabolic Pathways in Liver of LDL Receptor Deficient Mice.3,5,3'-三碘-L-甲状腺原氨酸和3,5-二碘-L-甲状腺原氨酸对低密度脂蛋白受体缺陷小鼠肝脏代谢途径的影响。
Front Physiol. 2016 Nov 17;7:545. doi: 10.3389/fphys.2016.00545. eCollection 2016.